作者:吕开阳 & 本地AI
作者:吕开阳 & 本地AI | 检索数据库:PubMed(NCBI E-utilities,9组检索式);去重题录 1 106 条,CO2相关 771 条,逐条分析 486 条;正文引文 209 条
全文 Word 文档:(可直接下载)。
关键词:剥脱性点阵激光;CO2激光;点阵光热解;瘢痕;光老化;激光辅助给药;综述
1. 引言
点阵光热解(fractional photothermolysis)概念于2004年前后提出:激光束以微束阵列作用于皮肤,仅产生若干边界清晰的显微治疗区(microscopic treatment zones, MTZ),其间的正常皮肤完整保留,从而显著加快修复、降低剥脱性激光的并发症[1]。CO2激光波长10600 nm,被水强吸收,兼具精确气化剥脱与止血能力,是点阵激光中应用最广的剥脱性设备[2][3]。早期研究在组织学上证实MTZ内表皮消融、凝固带形成及经表皮排出真皮内容物[4][5],并很快用于萎缩性瘢痕、手术瘢痕、痤疮后红斑、光老化与黄褐斑[6][7][8][9][10]。
经过二十余年发展,剥脱性CO2点阵激光(下称点阵CO2激光,ablative fractional CO2 laser, AFL/fxCO2)的适应证从美容重建扩展到瘢痕管理、色素病、皮肤移植辅助、妇科与毛发等领域,形成机制研究、参数优化与联合治疗三位一体的证据体系。本文基于PubMed系统检索,对其临床应用与作用机制文献进行描述性综述。
2. 检索方法与文献概况
检索数据库为PubMed(NCBI E-utilities),检索式围绕ablative fractional / fractional CO2 / fractional carbon dioxide laser核心词,设9组主题检索式(总览、机制、瘢痕、年轻化、色素与其他适应证、综述与meta、联合治疗、安全性、儿童),时间范围2004-01-01至2026-11-12。共检得去重题录1 106条,抓取题录与摘要1 100条;以CO2/carbon dioxide文本过滤保留771条,按主题自动分桶486条进入逐条分析(各桶保留检索相关度前100-110条),另存未分类20条。经典早期文献(2004-2007)以主题词加年代限定补充检索。分析采用9个并行AI代理逐主题阅读摘要,形成要点并逐一标注PMID,正文引文按首次出现顺序编号。
3. 作用与生物学机制
该主题文件围绕剥脱性CO2点阵激光(10600nm)的生物学机制展开:核心原理为点阵光热解——在皮肤形成边界清晰的显微治疗区(MTZ),动物研究测量消融深度约76.9-97.2µm、凝固深度约186-220µm,并可用离体双模式共聚焦显微直接可视化。主流结论:可控热损伤触发创伤愈合级联,早期招募巨噬细胞并转归愈合表型,调控MMP、TGF-β、热休克蛋白、miRNA与bFGF,驱动I/III型胶原、弹性纤维及细胞外基质重塑,此在眼睑、肥厚性瘢痕、阴道黏膜等人体活检中均有组织学证据;中性粒细胞及其胞外捕网(NETs)对重塑有负面影响;黑素细胞数量与酪氨酸酶通路下调,氨甲环酸、PRP、EGF、bFGF等辅助可增强胶原合成并减轻副作用;激光辅助给药可行,但MTZ通道因纤维蛋白栓快速形成,即时渗透受限,需把握给药时机。证据以动物、离体和人体活检研究为主;文件中热休克反应的直接实验证据缺失(仅综述提及),MMP-2升高仅见于阴道黏膜单一研究,人体在体机制类RCT整体稀缺。
[11]: 机制综述指出,剥脱性CO2激光通过在治疗修复各阶段调控MMP、TGF-β、热休克蛋白、miRNA和bFGF等关键因子,促进再上皮化、新生血管、细胞增殖与胶原重塑,以精准热损伤调节组织修复从而改善瘢痕外观。
[12]: 10600nm剥脱性点阵激光基于点阵光热解原理创建多个显微治疗区(MTZ),加速胶原形成与再上皮化;需重复治疗,易致红斑、水肿、感染及炎症后色素沉着,联合其他疗法可提高安全性。
[13]: 离体猪皮肤双模式共聚焦显微(RCM+FCM)可完整显示MTZ的宽度与深度及与 intact 皮肤的清晰界限,荧光模式下CO2激光后的表皮消融清晰可见,为热损伤量化提供直接可视化证据。
[14]: 大鼠实验测得MTZ消融深度76.90-97.18µm、凝固深度186.01-219.84µm;高能设置即刻皮肤收缩最强,低能量结合脉冲堆叠可维持30-60天的持续收缩,是更安全的紧致方案。
[15]: 分脸设计利用上睑成形术获取的皮肤标本,以Picrosirius Red染色客观量化I/III型胶原,评估眼周点阵CO2激光诱发的胶原新生与重塑; [16]: 低能量低密度单次治疗(5%密度、10mJ)在D0与D84对I/III型胶原、弹性纤维及表皮厚度作定量组织学比较并见临床皱纹改善。
[17]: 烧伤瘢痕经10次点阵CO2激光治疗,VSS显著下降,治疗前后活检显示组织学重塑; [18]: 肥厚性瘢痕自身对照、每月1次共5次,采用VSS/POSAS临床评分加组织病理学评估疗效与安全性。
[19]: 小鼠单次AFL(100mJ/微束、5%密度)治疗第5天,流式细胞术与组织学显示巨噬细胞浸润,Arg1、MHC II、CD206等标志改变,促进皮肤巨噬细胞向创伤愈合表型转化。
[20]: 小鼠模型中中性粒细胞主导AFL早期炎症反应,RNA测序、Ly6G抗体耗减及免疫荧光显示中性粒细胞及其胞外捕网(NETs)损害点阵CO2激光诱导的真皮重塑,重塑以CD31阳性血管增多为特征。
[21]: 烧伤后肥厚性瘢痕CO2激光与点阵微针射频自身对照,H&E、orcein染色及组织TGF-β1水平检测显示两组均显著改善,CO2组POSAS观察者评分及弹性纤维分级改善更优(p=0.025)。
[22]: 重度烧伤瘢痕机制先导研究:免疫组化示治疗2次后Langerhans细胞减少39%,瘢痕内神经元细胞治疗前过表达91%、治疗后恢复至接近正常水平,角质细胞11β-HSD1表达显著升高,提示重塑及瘙痒相关机制。
[23]: 新西兰白兔肥厚性瘢痕模型中,artesunate联合点阵CO2激光通过调控BMP-7与Fas表达(免疫组化、Western blot、RT-QPCR)增强疗效,阐明联合治疗的分子机制; [24]: 建立Red Duroc猪III度烧伤后70天肥厚性瘢痕模型,用于比较CO2与Er:YAG剥脱点阵激光的组织病理与生化重塑机制。
[25]: 小鼠脱发模型单细胞转录组分析:启动毛发生长周期的有效条件是15mJ/光点、产生约500µm深度光柱、不穿透真皮、密度约1点/mm²,通过单细胞RNA测序解析照射皮肤的细胞群与基因表达。
[26]: Wistar大鼠实验评估光生物调节(PBM)对点阵CO2激光后胶原重塑的影响(细胞外基质厚度、I型胶原),PBM有加速恢复、改善组织再生、减轻副作用的潜力; [27]: C57BL/6小鼠实验证实532nm低能量绿光激光可促进CO2点阵激光后的伤口愈合。
[28]: 以点阵CO2激光处理过的角质细胞条件培养基培养小鼠及人黑素细胞,氨甲环酸降低黑素含量、酪氨酸酶活性及酪氨酸酶、TRP-1、TRP-2蛋白水平,抑制激光诱导的黑素生成; [29]: 黄褐斑两次点阵CO2激光治疗后MASI评分降低48%,光镜显示黑素细胞计数显著减少,电镜评估超微结构改变。
[30]: 活体猪模型:剥脱点阵CO2激光(MTZ 120µm光点、5%覆盖率)后数分钟内MTZ通道内快速形成纤维蛋白栓,阻碍即时经激光通道的外用药物输送; [31]: 人体在体多光子荧光寿命成像示AFL后透明质酸可被可视化于全部表皮层及上真皮,完整皮肤仅达表层,证实激光辅助给药穿透增强。
[32]: 分臂对照:fxCO2激光后应用PRP侧TEWL恢复更快、红斑指数更低,第28天活检显示胶原束更厚; [33]: FCL联合PRP或干细胞条件培养基分脸试验,治疗后活检示真皮胶原增加、前胶原I型基因表达上调,PRP侧改善更快(p=0.006)。
[34]: 回顾性队列(123例)示点阵CO2激光联合牛bFGF凝胶治疗面部成熟烫伤瘢痕,PSAS(7.74±2.15对9.41±1.97)与OSAS(11.34对12.96)评分组间差异显著(P<0.01); [35]: 点阵CO2激光促进重组人胶原渗透用于眼周年轻化,3个月自对照示下睑细纹减少47.3%、下睑肤质改善41.4%、静态鱼尾纹减少35.0%。
[36]: 绝经后萎缩性阴道黏膜活检的电镜与光镜示点阵CO2激光后厚层鳞状上皮恢复、糖原储存显著、固有层成纤维细胞活跃合成新胶原及基质,结缔组织乳突与毛细血管再生; [37]: 单次激光后1小时即见上皮增厚、新薄III型胶原纤维形成,伴随金属蛋白酶-2(MMP-2)升高及新生血管,为早期重塑机制提供证据。
4. 临床应用
4.1 痤疮瘢痕
文件中痤疮瘢痕相关证据以萎缩性痤疮瘢痕为主,包含1篇纳入30项研究(12项回顾、18项前瞻性RCT)的系统评价、多篇meta与网络meta、约12项split-face随机对照试验及数项回顾队列。主流结论一致:剥脱性点阵CO2(10600 nm)是有效的核心手段,121例队列首次治疗中-优改善率50.4%,需多次治疗且能量/密度参数须个体化;滚动型与boxcar型反应优于冰锥型,高能量组更佳。联合治疗证据最充分的是自体PRP(9项meta、13项672例MD 0.55、>50%改善OR 1.63)与皮下剥离(413例回顾P<0.001、30例RCT P=0.007),生长因子(rhEGF/bFGF/L-GFs)、透明质酸敷料及术后替莫洛尔亦有支持证据。缺失证据如实说明:无统一参数与疗程共识;随访多为1-6个月;样本量普遍≤45例;深肤色色素安全性数据少;32例split-face试验中PRP联合组与单用组无统计学差异,头对头结果方向不一(调Q 1064优于CO2 vs CO2优于Er:YAG);部分摘要在文件中被截断,疗效幅度与方向无法完全确定。
[2], 29304516: CO2激光10600 nm中红外被皮肤水分强吸收,适合精确、安全的气化剥脱兼止血;纳入30项研究(12项回顾+18项前瞻性RCT)的系统评价确立剥脱性点阵CO2为痤疮萎缩性瘢痕的有效疗法,治疗次数、间隔与参数须个体化,并应考虑联合治疗。
[38]: 121例超脉冲点阵CO2共206次治疗(人均1.7次),首次治疗后中-优改善率达50.4%,提示单次治疗不足,通常需要多次疗程。
[38], 37639055: 多因素分析显示滚动型对点阵CO2的反应优于冰锥型(OR 7.3,95%CI 1.2-43.4,P=0.029),高能量组改善更显著;413例回顾中联合皮下剥离组对boxcar与滚动型的ECCA显著低于单用激光(P=0.041、P<0.001)。
[39], 34932873: 75例单臂盲评队列中30例痤疮瘢痕仅30%达“好-很好”,仅半数患者满意,疗效预期应现实;67例非痤疮瘢痕数据提示早期、无色素沉着、浅肤色者效果更好,深肤色须警惕色素风险。
[40], 30809666: 两项meta分析(9项研究;4项合格研究含3项RCT)显示点阵CO2联合自体PRP在临床改善评分、改善率、患者满意度及结痂期均优于激光单用,且更安全。
[41], 36660635: 13项672例meta中CO2+PRP改善评分MD 0.55(95%CI 0.40-0.70),>50%改善的OR为1.63(1.10-2.42);网络meta中FCL+PRP在瘢痕改善排序居首(SUCRA 0.699)。
[42]: 60例三臂随机比较(PRP单用、CO2单用、CO2+PRP),联合组临床反应最佳、副作用更少、恢复期更短,并含免疫组织病理学评估支持。
[43]: 32例split-face、3次(间隔6周)治疗,双侧均显著改善,但PRP联合与CO2单用在Goodman & Baron定性(P 0.9115)与定量评分上无统计学差异,提示联合获益不稳定。
[44], 37841061: 生长因子是受支持的联合手段:2026年rhEGF+点阵CO2治疗萎缩性痤疮瘢痕的RCT系统评价已注册PROSPERO(结论段在文件中截断);120例RCT显示牛bFGF+超脉冲点阵CO2总反应率高于单用激光(P<0.05)。
[45]: 45例激光辅助递送标准化冻干生长因子(L-GFs),双侧ECCA与Goodman & Baron评分显著下降,L-GFs侧临床改善与满意度更高、恢复期更短。
[46]: 6项RCT共623例meta显示点阵CO2+透明质酸敷料较单用激光降低ECCA评分(MD -3.37,95%CI -5.03~-1.70),并以Cochrane工具与GRADE评估偏倚与证据质量。
[47], 42178734: 皮下剥离联合点阵CO2证据较强——413例回顾联合组疗效显著高于单用(P<0.001);30例RCT中CO2+皮下剥离的瘢痕改善优于单用CO2(P=0.007)。
[48]: 42例以1470 nm光纤行“皮下激光辅助瘢痕剥离(SLASS)”并同次联合点阵CO2(20-30%密度),ECCA平均降低92.6±34.3分(P<0.05),对滚动型纤维牵拉机制针对性强。
[49], 27631461: 34例split-face比较同步与序贯的CO2+皮下剥离(3次、间隔1个月)疗效相当(不良反应差异在原文截断处);114例以肿胀麻醉+20% TCA剥脱+广泛剥离+点阵CO2单次治疗滚动型,平均改善2.9(1-4分制),90%满意。
[50], 26579867: 头对头方向不一——20例双盲split-face中调Q 1064 nm Nd:YAG改善33.33%高于点阵CO2的17.37%(Sharquie评分),且疗效与年龄负相关;14例4次治疗中数字照片显示点阵CO2疗效高于Er:YAG。
[51], 39122490: 与微针/射频类比较——30例单次split-face显示非绝缘微针射频与剥脱性点阵CO2疗效相当(P>0.05)、约95%满意,但CO2侧疼痛更明显;9例微针vs点阵CO2在3个月后总瘢痕、冰锥与滚动型评分均显著下降(P=0.0005、0.0128、0.0007)。
[52], 41195573: 术后创面护理影响恢复与结局——25例双盲安慰剂对照显示0.5%替莫洛尔显著促进激光后皮肤屏障恢复;15例split-face比较硅凝胶与白凡士林,硅凝胶侧红斑、瘙痒、结痂更多,VISIA红度、卟啉与质地变化更差(P=0.04),提示更易出现痤疮样疹。
[53]: 25例痘后色素沉着split-face试验中,低功率低密度点阵CO2(每4周)与氨甲环酸微注入(每2周)均显著降低PAHPI与黑色素指数(P<0.001),皮肤镜总评分改善率有统计学差异(方向在摘要截断处)。
4.2 烧伤瘢痕、增生性瘢痕与瘢痕疙瘩
剥脱性10600nm点阵CO2激光治疗烧伤瘢痕、增生性瘢痕与瘢痕疙瘩的证据近十余年快速积累,包括病例系列、前瞻队列、少量RCT与多篇系统评价/meta分析。总体结论一致:治疗可显著降低VSS/POSAS评分,合并数据显示282例患者VSS平均改善约29%,厚度、柔软度、色素、血管性改善明显,并减轻疼痛瘙痒、改善睡眠与生活质量、减少择期重建手术及住院天数。常见疗程为每月1次共3-5次,能量约30W/50-100mJ、密度约200点/cm²;激光穿透深度中位约900μm,常小于瘢痕厚度,疗效与穿透深度相关。主流方向是联合治疗:PDL联合AFCL证据最多,RCT示联合优于单用,但网络meta分析PDL总VSS优于联合,结论有争议;激光辅助递药(激素、BTX-A、5-FU、曲伏前列素)、PDT、PRP、冷冻、射频等辅助兴起。局限:参数与最佳介入时间无共识、高质量RCT少、儿童试验早期终止、客观功能与长期复发证据缺乏、利用率仅约8.8%。文件中大量题录(阴道萎缩、白癜风、葡萄酒色斑、毛发移植等)与本主题无关,未纳入要点。
[54], [55]: 系统评价与meta分析显示剥脱性点阵CO2激光治疗烧伤瘢痕后VSS平均改善29%(8项研究、282例);针对增生性瘢痕与瘢痕疙瘩,CO2激光单疗的VSS及改善率显著优于其他激光,但颜色、柔软度、高度、血管性改善及满意度无显著差异(7项研究、404例、506处瘢痕)。
[56], [57]: 前瞻队列(47例、118处瘢痕)系统采集客观(VSS、POSAS、超声瘢痕厚度)与主观(神经病理性疼痛、瘙痒、BSHS-B生活质量)结局并按瘢痕成熟度分层;对照研究(167例 vs 20例保守治疗)示单次AFL-CO2后超声瘢痕厚度与VSS显著下降,对照组无显著改善,POSAS-O两组均改善。
[58], [59]: 儿童烧伤增生性瘢痕证据充分:49例180次治疗中,观察者POSAS色素、厚度、起伏、柔软度、面积自首次治疗后显著改善并持续至末次;99例332次激光(中位烧伤时年龄4.0岁)使躯干前侧、上肢、下肢mVSS及色素、血管性显著改善。
[60], [61]: 干预时机是研究热点:221例按伤后至首次激光时间分为≤1月、1-3月、3-6月、6-12月、>12月五组,末次治疗后1个月评估VSS、硬度计与色度,旨在验证伤后3个月内的早期干预;另有60%TBSA全面部烧伤病例在伤后6周即启动AFR,以非手术方式控制口周挛缩与眼睑外翻。
[62], [63]: 常用参数与疗程为30W、脉冲能量50mJ、密度200点/cm²、每passes 3遍并擦除凝血痂、每月1次共4次;系统评价统计剥脱点阵激光平均3.43次、PDL平均3.68次、两者联合平均1.5次,AFL的VSS有效率57.5%、POSAS有效率40.4%。
[64]: 穿透深度决定疗效:78例158处瘢痕中位厚度3400μm、中位激光穿透900μm,单次治疗后最大瘢痕厚度中位减少800μm(P<0.001),但效应依赖穿透深度,多数瘢痕穿透仅占厚度的25-50%(67处)或0-25%(40处),完全穿透者极少。
[65], [66]: 联合治疗为主流方向:单盲RCT中PDL、AFCL、联合组均显著改善VSS、颜色、血管床、高度与柔软度,联合组改善最突出;系统评价(8项研究、497例,平均年龄7.18岁,62%烫伤)显示595nm PDL联合10600nm AFCL显著改善儿童烧伤瘢痕VSS/POSAS。
[67], [62]: 联合证据存在争议:11项研究的网络meta分析显示PDL总VSS降低显著优于联合治疗(MD=-0.90),AFCL与联合无显著差异;而35例自身对照研究显示FCO2(30W、50mJ、200点/cm²、4个月4次)与585nm PDL疗效相当(VSS 4.26 vs 4.33)。
[68], [69]: 激光辅助递药(LADD)是重要增效手段:32例烧伤瘢痕每月接受点阵CO2 LADD,首次治疗即见mVSS色素、厚度、柔软度显著改善并持续至末次;30项研究综述指出能量设备辅助递药(含点阵激光、微血浆射频、超声)使用激素疗效与病灶内注射相当,且疼痛更少、皮肤萎缩与毛细血管扩张风险更低,对儿童尤为有益。
[70], [71]: 激素给药方式比较:瘢痕疙瘩RCT中病灶内曲安尼德注射组瘢痕体积降幅86.5%优于FCO2+外用曲安尼德组59.1%(P=.016),完全缓解72.7% vs 63.6%,复发18.2% vs 9.1%;针对VSS高度≥2的厚增生性瘢痕(155例,3次4周间隔),FCO2后外用 vs 注射曲安尼德以VSS、硬度计、色度比较,为给药路径优化提供依据。
[72], [73]: 激素联合与长期防复发:超脉冲FCO2+外用曲安尼德(40mg/ml)8次、4周间隔治疗难治性瘢痕疙瘩41例,24个月随访中POSAS各组件均显著改善且趋势持续;FCO2+病灶内曲安尼德(10mg/ml)与注射单药对照(各25例、4次),以MQS与患者满意度评估联合方案。
[74], [75]: A型肉毒毒素成为新联合选项:16例3臂自身对照显示FCO2+病灶内BTX-A的VSS降幅达58.25%,优于FCO2单疗及FCO2+LADD递BTX-A;张力区增生性瘢痕3臂研究(BTX-A双平面微滴注射、曲安尼德、CO2点阵)24个月随访中,BTX-A与CO2点阵组评分持续下降,而曲安尼德组3个月后反弹。
[76], [77]: 光动力与PRP为辅助选项:FCO2(26-28W)预处理制造微热区后行5-ALA+635nm红光(120J/cm²)PDT治疗瘢痕疙瘩12例、每2周重复,以克服ALA穿透不足;67例烧伤/外伤瘢痕随机对照比较FCL+自体PRP与FCL单疗(每月1次共4次,POSAS评估)。
[78], [79]: 系统药与外用药物联合:盲法RCT显示口服己酮可可碱400mg每日2次×4个月联合FCO2治疗增生性/瘢痕疙瘩样烧伤瘢痕,两组mVSS均显著下降(自7.73降至4.x),组间比较细节在摘要中未完整呈现;双盲RCT评估0.005%曲伏前列素(vs 生理盐水,每日2次×6个月)联合6次FCO2治疗色素减退烧伤瘢痕的再色素化。
[80], [81]: 瘢痕疙瘩主张多模式联合:1550nm非剥脱+10600nm剥脱CO2序贯激光后即刻行表浅冷冻与病灶内曲安尼德注射(35例),VSS总分及子项显著改善,高度与柔软度应答最快最显著;170例随机比较冷冻+病灶内激素与FCO2+外用倍他米松(各4次),两组疗效差异显著(摘要结论方向在文件中被截断)。
[82], [83]: 设备间比较:10600nm CO2点阵治疗增生性瘢痕VSS改善率49.8%,优于2940nm Er:YAG的28.2%,改善集中于柔软度,血管性与色素无显著变化;10篇系统评价中60%的文献显示微针/RF针/中meso针与剥脱点阵激光(CO2、Er:YAG)疗效无显著差异,两者均显著改善。
[84], [85]: 生活质量与睡眠为重要结局:≥30%TBSA大面积烧伤的嵌套病例对照研究显示CO2-AFL改善生活质量(主要指标SF-36与BSHS-B);68例前瞻队列(AFL 35例、传统手术33例)中CO2-AFL组PSQI睡眠总分显著低于传统手术,疼痛与瘙痒亦获改善。
[86], [87]: 儿童睡眠与手术负担:9例增生性瘢痕儿童经客观睡眠监测证实AFL-CO2改善睡眠效率、深睡时长、觉醒时间及呼吸暂停低通气指数;引入AFR后2.5年内传统重建手术占比降至23.9%,平均住院日1.96 vs 0.36天(P<0.001)、麻醉时长由90分钟降至64分钟。
4.3 手术瘢痕、外伤瘢痕及其他瘢痕
本主题聚焦点阵CO2激光(10600nm)在手术瘢痕(甲状腺切除、皮肤癌术后、剖宫产、唇腭裂、头颈切口)和外伤后瘢痕(面部线性伤、眉缺损、风挡伤)及激光重建其他适应证(颈部和手部光老化、手术辅助)中的证据。两项Meta分析合计22项对照试验证实fCO2显著降低VSS(P<0.00001);多项RCT和前瞻性研究支持术后2-4周早期干预可改善瘢痕预防。联合PRP、Er:YAG、PDL和激光辅助药物递送可增效。激光重建用于颈部/手部光老化一致有效,睑成形术和上臂成形辅助亦安全。局限:多数证据为回顾性或小样本,大样本多中心RCT仍为空白;超参数治疗可致严重瘢痕和睑外翻,需规范能量参数。
[88]: 手术瘢痕fCO2系统综述与Meta分析纳入14项对照试验492例,RCT和非RCT中fCO2均显著改善手术瘢痕; [89]: 10项研究(6项RCT+4项N-RCT)Meta分析,fCO2显著降低VSS(P<0.00001),在色素、血管性、柔韧性和高度四项均有改善
[90]: 116例手术瘢痕RCT,fCO2组6个月时POSAS、VSS、DAS和VAS均显著优于注射治疗组(P<0.05),患者满意度更高
[91]: 22例皮肤癌术后瘢痕fCO2治疗,VSS降低44.5%(P<0.001),所有参数(色素除外)显著改善,疗效不限早期瘢痕; [92]: 40例面部皮肤癌术后瘢痕,患者、非医学人员和专家均评价瘢痕质量显著改善,满意度高
[93]: 28例甲状腺切除瘢痕,术后1月启动早期AFL(5次)在VSS上显著优于晚期和未治疗; [94]: 12例甲状腺切除瘢痕,fCO2联合类固醇(乳膏vs溶液)一年后POSAS改善,外观有适度改善
[95]: 120例唇腭裂瘢痕,术后3周(早期)和3月(较晚)使用5-7次fCO2均优于局部乳膏对照; [96]: 12例唇腭裂瘢痕5次fCO2改善外观(1.29±0.86)、症状(评分)和满意度(P<0.001)
[97]: 79例剖宫产瘢痕(平均28.1岁),fCO2治疗在VSS(t=16.75)、UNC4P(t=15.63)及Antera3D颜色/纹理均显著改善(P<0.05),无长期并发症
[98]: 27例深肤色术后瘢痕(术后4周启动fCO2),VSS从5.33±1.33降至2.55±1.06(P≤0.001),色素、高度和柔韧性最显著改善; [99]: 47例面部瘢痕,术后2周和4周启动5次激光(PDL+fCO2),Antera3D和POSAS均显著改善,时机差异小
[100]: 20例外伤后瘢痕自身对照,PRP+fCO2 VSS从7.0降至3.25,优于fCO2单用(6.75→3.85)(P=.001),副作用更少; [101]: 39例面部长线性外伤瘢痕,PDL(2次)+CO2-AFL(3次)序贯5次,POSAS(P<0.05)和Antera3D粗糙度均显著改善
[102]: 60例严重外伤和病理瘢痕(12-15月随访),ultrapulsed fractional CO2在MSS评分显著改善; [103]: 2例风挡玻璃伤后残留玻璃碎片形成丘疹/结节样瘢痕,fCO2治疗后碎片自损伤部位排出
[104]: 12例萎缩性手术/外伤后瘢痕经3次AFR后三维光学轮廓显示体积改善,纹理、色素和整体外观改善; [105]: 25例亚洲萎缩性瘢痕(中-重度),超脉冲CO2+fCO2联合(2-5次,间隔3-6月),外观显著改善
[106]: 39例面部瘢痕回顾性分析,Er:YAG(2940nm)+fCO2(10600nm)联合治疗,在色素、高度、血管性和柔韧性均分析改善(早干预vs延迟干预); [107]: 2024年RCT比较fCO2与Er:YAG在成熟和未成熟瘢痕的疗效(摘要未展开具体结果)
[108]: 10例颈部AFR重建前瞻研究(1-3次),纹理改善62.9%,松弛57.0%,皱纹51.4%; [109]: 10例手部AFR(3次,4-6周间隔),色素改善51-75%,纹理26-75%,皱纹26-50%
[110]: 30例上睑成形同期fCO2重建,皱纹改善均值42%,1例伤口裂开自行愈合; [111]: 首例fCO2用于上臂轮廓成形,成功减少皮肤松弛,改善皮肤纹理
[112]: 4例(54-67岁女性)面/颈部fCO2后出现瘢痕和睑外翻,与过度能量参数相关; [113]: 45岁女性颈部fCO2后出现显著红斑、肿胀和皮肤紧缩,需降低参数
[114]: 20例181病灶RCT,fCO2+外用锑剂VAS(3.5)显著低于注射(6.85)(P<0.001),美容结局更优(P=0.001); [115]: 120例RCT,6次fCO2(间隔3周)优于1次ablative CO2治疗利什曼病瘢痕(P<0.05)
[116]: LADD综述,fCO2产生微消融通道增强皮质类固醇、光敏剂和免疫调节剂(咪喹莫特/5-FU)吸收,用于瘢痕、皮肤癌和光损伤; [94]: LADD将类固醇递送至甲状腺切除瘢痕,1年后POSAS改善
[117]: 24例纹痕双侧对照(3次),fCO2+PRP与fCO2均改善,双侧比较; [118]: 40例纹痕,fCO2与IPL均显著改善(P<0.05),第5次后改善更明显
[119]: 72例手术切口瘢痕(≥2年,4次fCO2),Antera3D颜色/纹理/黑色素均显著降低(P<0.05); [120]: 25例儿童(平均9.88岁)面部切除后SWTRD+CO2-AFL预防瘢痕,瘢痕宽度窄,6月UNC4P显著降低
4.4 光老化、光损伤与皮肤质地
在剥脱性CO2点阵激光(10600 nm)与光老化、光损伤、皱纹、皮肤质地及年轻化主题的PubMed题录中,文件共约24条记录,其中约14条与本主题直接相关。证据以中小样本的前瞻性、split-face(左右脸对照)随机对照及盲法照片评估为主,样本量多在10–100例,随访以3个月为主。主流结论一致:剥脱性点阵CO2可显著改善皱纹、色素不均、皮肤粗糙、松弛和整体外观,多项研究显示疗效在数月至1年内维持,并有超声学证据提示真皮增厚、太阳弹力样物质减少,机制上支持“年轻化”并非仅表面重塑。第二共识是“激光+外用药物/活性成分”的联合增效:肉毒毒素、聚左乳酸、白藜芦醇、氨甲环酸、曲安西龙、辅药及超声透药均安全增效,并能预防术后色素沉着;同时有比较证据显示点阵CO2对毛孔扩张优于碳介导Q开关Nd:YAG,且与Er:YAG均可改善皱纹。证据缺口亦明显:缺乏长期(1年以上)大样本随机对照、颈部/胸部及深肤色人群的专门研究,部分条目(如中国面部衰老研究、Er:YAG对比研究)摘要在文中被截断,无法据其得出完整结论;另有若干记录缺年份,refs中留空。
[121]: 对光损伤面部皮肤行剥脱性点阵光热解,3个月时色素不均改善61.0%、皮肤松弛54.3%、皱纹51.5%、整体美容结局60.2%,均达半数以上改善,说明其对光老化多维征象同时起效。
[121]: 超声测量显示皮下低回声带(SLEB,即充满太阳弹力样物质的乳头层)由0.078降至0.038 cm(减少40%,p<0.001),总皮肤厚度增加10.3%(p<0.05),提示剥脱性点阵CO2可重塑真皮、减少光损伤弹力物质,年轻化有客观影像学依据。
[122]: 非顺序式超脉冲点阵CO2(ActiveFX)单次单遍全脸治疗55例光老化皮肤,除毛细血管扩张外,细纹、斑驳色素、肤色发黄、触觉粗糙、粗皱纹及总分在1和3个月均显著改善(p<0.05),验证“温和”单次全脸方案的可行性。
[123]: 8例健康志愿者左右脸分别用滚动手具与冲压手具两种剥脱性点阵CO2设备,3个月时皱纹、色素、松弛和整体外观均改善,两设备临床疗效无显著差异,但术中时间与疼痛评分有明显差别。
[124]: 100例眼周皱纹、组织松弛、光老化伴中度眼睑松弛者接受1至4次扫描手具点阵CO2“fractional eyelift”,约半数在12个月维持26–50%改善,近40%在6和12个月维持1–2 mm眉位提升,红斑水肿仅持续3–4天,满意度高。
[125]: 25例下睑松弛与光老化采用单次、多遍、低点密度(100点/cm2,10600 nm ablative fractional,YouLaser)剥脱性点阵重建治疗,两位盲法评估者评分无显著差异(p=0.88),患者满意度与医师评级一致,为单_session低风险眼周年轻化技术。
[126]: 40例面部皱纹采用随机双盲split-face设计,一侧剥脱性点阵CO2、一侧点阵Er:YAG,每月1次共3次,由两名独立皮肤科医师临床评估并用生物测量仪测皮肤共振运行时间(CRRT),记录不良反应与满意度;文中小结部分被截断,只能确认其设计与两者均用于皱纹治疗。
[127]: 10例鱼尾纹患者点阵CO2后一侧外涂A型肉毒毒素、一侧用生理盐水对照,外涂组皱纹改善有临床显著优势(1周时差异明显),而此前研究已证实单独外涂肉毒毒素几乎无皮肤生物利用度,说明激光通道是透药增效的关键。
[128]: 10例中重度上唇皱纹接受3次低密度点阵CO2后外用聚左乳酸(PLLA)混悬液,治疗3次后皱纹严重度经计算机分析平均下降47%(p<0.05),除预期激光后红斑外无非预期不良事件,证明激光辅助递送PLLA治疗口周皱纹的安全性。
[129]: 32例皮肤光老化者左/右脸接受剥脱性点阵CO2并配合白藜芦醇精华,6个月时激光侧改善优于单纯用药对照组(p<0.05),黑色素指数在入组后2、3、4个月的变化更明显,表明抗氧化外用与点阵CO2联合可增效改善光老化。
[130]: 14例双盲随机split-face研究,一侧单用点阵CO2,另一侧点阵CO2+声学压力超声透递药化妆品,6个月时联合侧在细纹、皱纹和整体面部衰老评分上更优(p<0.01),两项参数均较基线显著改善(p<0.001),提示透药增强年轻化效果。
[131]: 随机split-face研究,低功率点阵CO2联合外用氨甲环酸每3周1次共4次,MASI评分显著下降且降幅高于对照,皮肤镜证实皮损呈网状球状/颗粒点状、无结构性色素且毛细血管扩张减轻,为光损伤相关色素问题提供联合方案证据。
[132]: 随机对照试验显示4% pidobenzone作为点阵CO2或冷冻治疗的辅助,可安全提高日光性雀斑样痣疗效,并预防治疗后色素沉着(postiatrogenic hyperchromia),其中冷冻+pidobenzone组合最为有效。
[133]: 80例面部毛孔扩张,每月1次共3次,点阵CO2与碳介导Q开关Nd:YAG均显著改善,但点阵CO2临床应答统计学更高、维持时间更长(p=0.01),提示对毛孔扩张这一质地问题剥脱性方案更具优势。
[134]: 29例面部衰老女性接受最多3次剥脱性点阵CO2,面部衰老评分由11.24±4.30降至10.51±3.86(p=0.003),但62.1%仅为轻度改善、无显著或完美改善,7个类别中仅“肤色”改善有统计学意义(p=0.0001),提示期望值需合理设定;随访至末次治疗后3年。
[135]: 12例细纹女性双脸对照比较“moveo”快速扫描仪模式与标准模式,仅2次治疗即获得美学改善,以三维临床照片、GAIS及皮肤镜评估均匀性与覆盖面,并记录治疗时间与副作用,说明快速扫描模式可缩短全脸年轻化治疗时长。
[136]: 综述指出脉冲式剥脱性CO2仍是皮肤年轻化的“金标准”,在创新术后护理下并发症显著降低;作者按患者与皮肤状况个体化,将点阵CO2与脂肪移植、面部提升联合,激光作为面颈部提升手术的辅助手段。
证据缺失说明:[137](超脉冲点阵CO2治疗中国面部衰老,2022)在文件中无摘要,无法据其得出疗效结论;文中亦缺乏以亚洲人群/颈部及胸部光老化为对象的专门研究、以非激光美容为对照的皱纹头对头试验,以及1年以上的大样本随机对照,长期获益与最佳治疗间隔证据不足。
4.5 色素性疾病
文件内证据集中于白癜风与黄褐斑,痣相关证据极少。白癜风证据最充分:多项系统综述与meta分析支持剥脱性点阵CO2(10600 nm)作为增效治疗,与NB-UVB、308 nm准分子、PRP、5-FU、糖皮质激素、MTX联合可显著改善再色素化(≥50%再色素RR可达4.9),肢端型亦有效,且部分研究随访2-8年疗效持久、副作用轻微;但也有半体随机对照研究(p=0.11)显示联合NB-UVB无额外获益,结论尚有争议,参数上低能量低密度更耐受。黄褐斑证据以分面小试验为主,核心策略是激光联合经皮递传氨甲环酸、氢醌等,联合方案疗效与微针相当;网络meta分析显示联合外用药优于单激光,1064 nm皮秒在MASI改善上优于低功率点阵CO2,低功率CO2联合QS调Q可减轻点状白细胞减少等安全数据提示联合方案更安全。痣仅见太田痣联合治疗与皮脂腺痣治疗记录,无黑色素细胞痣、咖啡斑、炎症后色素沉着及白癜风以外色素减退的直接研究,此为主题证据缺口。黑变病等附属色素问题有小样本提示有效。总体:白癜风联合证据较扎实,黄褐斑宜联合且需权衡风险,痣与色素减退证据薄弱。
[138]:系统综述与meta分析(6项研究85人)显示,顽固性白癜风在常规治疗上加用点阵CO2激光,>50%再色素(RR 4.90)、医生评分、患者满意度均显著优于单用常规治疗,副作用轻微。
[139]:meta分析(6项研究184处/例)显示,稳定型非节段性白癜风联合点阵CO2与常规治疗显著优于对照:≥75%再色素RR 2.80(95%CI 1.29-6.07),≥50%再色素RR 2.26。
[140]:12项RCT共1064例的meta分析及试验序贯分析显示,点阵CO2联合308 nm准分子激光的优效率(≥75%再色素,RR 1.53)与良效率(50-75%,RR 1.14)显著高于对照组。
[141]:自身对照随机试验(10例对称皮损)显示,点阵CO2+NB-UVB的再色素及VASI改善显著优于NB-UVB单疗(P=0.025);[142]:纳入4项RCT的meta分析欲验证CO2+NB-UVB,作者承认其疗效仍存争议(摘要截尾)。
[143]:30例51对对称斑块半体随机,7次点阵CO2+NB-UVB组与NB-UVB单疗组再色素评分无显著差异(p=0.11);[144]:20例中激光侧VASI变化不显著(-2.6%),未证实加用激光获益。
[145]:30例肢端型非节段性白癜风,点阵剥脱CO2后外用5-FU,VESTA评分显著改善,盲法评估证实有效且安全;[146]:多中心289入组126完成,CO2激光助渗复方倍他米松+NB-UVB治疗肢端型,实验侧再色素更佳,总反应率51.6%。
[147]:42例稳定型白癜风,CO2激光递送MTX与5-FU均显著降低VASI、无组间差异,高能量+5-FU起效更早,+MTX随访期持续改善;[148]:CO2激光经皮递送5-FU组90%出现再色素、>50%改善率50%,病灶内注射组85%、55%(注射组再色素差异有统计学意义,摘要截尾)。
[149]:肢端/骨性突起顽固白癜风半体随机,CO2激光+倍他米松+NB-UVB三联使44%达>50%再色素,满意度高于对照,不良反应轻微可耐受;[150]:80例四臂对照,CO2+PRP组在再色素与满意度上取得最佳结果。
[151]:11项研究670例meta分析,CO2激光联合PRP的再色素平均改善等级显著优于单疗(MD 1.61,95%CI 0.24-2.99,P=0.02);[152]:30例自身对照,CO2+PRP与PRP单用均显著优于其他单疗,经VACAG、MISP及VAS证实。
[153]:48例参数优化,低能量60mJ+低密度8%组疗效优于高能量低密度组,与高能量高密度组无显著差异,且高能量组疼痛更重,提示低能量低密度耐受性更佳;[154]:64份 foreskin 预试验示15mJ、10%覆盖分布均匀副作用最小,并开展98例158处皮损三联联合RCT(结果摘要截尾)。
[155]:20例四分区设计,剥脱性10600 nm点阵CO2+NB-UVB+倍他米松达中到优改善、患者满意度高,非剥脱1565 nm激光无获益;[156]:CO2激光预处理+自体毛发移植+NB-UVB治疗顽固稳定白癜风,74%移植毛囊周围检测到毛囊周围再色素(摘要截尾)。
[157]:12例深肤色顽固黄褐斑回顾研究,41.7%患者mMASI降低>50%,33.3%达统计显著,CO2+传氨甲环酸组平均降幅最大,CO2+激光toning降幅最小,提示剥脱性激光在深肤色人群被低估使用。
[158]:分面试验(30例),CO2激光+外用TXA使mMASI降低55.82%,与微针+TXA(57.73%)相当,均P<0.001;[159]:TXA微注射±低功率CO2激光29例,黑素指数、红斑指数、皮肤镜评分双侧均显著降低,组间改善程度无显著差异。
[160]:39项研究1394人网络meta分析,QS Nd:YAG+外用药优于QS激光单用、Er:YAG+外用药、皮秒+外用药等,联合外用方案更优;[161]:20项研究1182人网络meta分析,低功率点阵CO2治疗后MASI高于1064 nm皮秒,提示皮秒疗效更优。
[162]:30例分面研究,低功率点阵CO2联合QS-Nd:YAG toning可降低点状白细胞减少(punctate leukoderma)发生率,改善低能量toning在深肤色黄褐斑中的安全性。
[163]:81例太田痣随机对照,1064 nm QS Nd:YAG+点阵CO2联合组>50%改善达25%,显著高于单用QS激光的5.71%;[164]:皮脂腺痣以点阵CO2后接力脉冲染料激光治疗, efficacy数据未载(仅标题级信息)。
[165]:20例假性黑变病分颈对照,点阵CO2侧20%优效、45%显著改善,明显优于TCA 20%剥脱侧(2%显著改善);[166]:系统综述纳入6项试验133例,比较点阵CO2、1550 nm铒光纤、长脉宽亚历山大激光与甘醇酸、TCA等外用药,结论部分摘要截尾。
[167]:30例眶周色素沉着分面对照,CO2+TXA与微针+TXA均显著改善,第60天激光侧显著更优,第30/90/150天两组无差异,满意度相当;[168]:20例毛角蛋白棘性角化病单次激光,12周30%皮损达中到好改善(p=0.02),角化性丘疹与色素沉着应答较好。
4.6 膨胀纹、皮肤移植与供区
主题文件含7条PubMed题录,全部聚焦膨胀纹(distensae、gravidarum、alba)治疗,以10600 nm剥脱/点阵CO2激光为核心工具,无皮肤移植、供区、刃厚皮片文献。证据概况:5条为随机对照试验,样本量小(16-40例),多条摘要在文件中截断致结论不完整,1条仅有标题无摘要。主要结论:1)点阵CO2激光对膨胀纹有效,微针与之疗效相当,LLLT疗效相当且无恢复期,FCO2数值上占优;2)生长因子辅助(自体PRP、冻干生长因子LGF、外用积雪草)是主流联合方向,多采用分侧身体自身对照;3)双器械联合(CO2+LLLT、微针射频+CO2)数值最有利。评估工具(INA、VAS、DLQI、四分位法、组织学)不统一,跨研究比较困难。移植/供区方向证据完全缺失,无法给出该类结论。
[169]:膨胀纹(striae distensae)为皮肤拉伸致真皮线性萎缩性凹陷的疾病;现有治疗包括外用药物、剥脱、微针、PRP及激光等多种方式,无标准疗法,但多种疗法可减轻临床症状。
[169]:22例膨胀纹患者接受点阵CO2激光联合外用积雪草(Centella asiatica)组合治疗,以膨胀纹评估指数(INA)和DLQI评分差异为分析指标;文件摘要截断,疗效方向未显示。
[170]:妊娠膨胀纹常见于初孕妇女并损害生活质量;16例随机双盲安慰剂对照试验将腹部左右分侧,均接受剥脱点阵CO2激光,PRP侧对照生理盐水侧,共3次、间隔4周,第6-16周照片独立评估(摘要在方法处截断,未显示疗效结论)。
[171]:该研究为首次报道冻干生长因子(LGF)用于膨胀纹治疗;LGF与PRP同属生长因子递送方式,LGF方法更标准化。
[171]:20例女性膨胀纹患者分三区域(CO2激光单独、LGF皮内注射单独、二者联合),各3次、间隔6周,治疗前后行临床与组织病理学评估,报告有统计学显著的临床及组织病理学改善(摘要截断,三区域优劣未显示)。
[170], [171]:剥脱点阵CO2激光联合生长因子(自体PRP或冻干LGF)是膨胀纹治疗的主要联合方向,两项研究均采用左右分侧自身对照设计。
[172]:40例膨胀纹白皙型(striae alba)患者(平均28.1岁),随机分侧接受微针与CO2点阵激光各4次、每月1次,随访10个月;两组最大膨胀纹截面中位数均显著减小(P<0.001),组间无统计学差异。
[172]:该试验中VAS评分两组均显著改善且组间无显著差异,即微针与CO2点阵激光治疗膨胀纹白皙型疗效相当。
[173]:30例III-IV光型膨胀纹白皙型患者随机分组,808 nm二极管低水平激光(LLLT,8-12次、每周2-3次)疗效与FCO2激光(每月2次)统计学相当,后者在数值上占优。
[173]:FCO2激光与LLLT同时联合组在全部疗效指标中数值最低(数值上最佳),即联合方案显示优势趋势。
[173]:LLLT组无恢复期(downtime),对患者满意度有积极影响,可与FCO2激光的疗效优势相互制衡。
[174]:标题报告韩国膨胀纹患者采用分次微针射频联合点阵CO2激光获得临床改善;该题录在文件中无摘要、年份空缺,无法评估具体数据。
[172], [169]:膨胀纹疗效评估工具不统一:前者用最大膨胀纹长度宽度、皮肤科医生评估、患者满意度和VAS,后者用INA和DLQI,另有研究用照片四分位法,跨研究比较与汇总困难。
[170], [171]:CO2激光辅助膨胀纹治疗的疗程模式为3次、间隔4-6周;微针治疗为4次、每月1次(见[172]的分组)。
[170], [171]:文件全部7条题录均为膨胀纹治疗研究,未见任何关于皮肤移植、供区瘢痕、刃厚(split-thickness)皮片或移植受区的文献,该主题方向证据缺失,无法得出相关结论。
4.7 其他适应证与联合技术
本主题围绕10600nm剥脱性点阵CO2激光的”其他适应证与联合技术”,核心是激光辅助给药(LADD):甲银屑病、甲真菌病、掌部多汗症、斑秃均有多个小型RCT,结论一致——”激光+外用药”优于单纯外用,可与病灶内注射疗效相当且疼痛更轻;甲真菌病完全清除率在RCT中达55%,而真实世界研究仅15.6%,提示实际疗效有限。鼻赘证据为观察性对比,点阵激光与冷刀手术美容结局相当(优良率71%比75%),可互为选项。化脓性汗腺炎仅一项n=20的RCT(CO2+长脉冲Nd:YAG联合优于单方)及小病例系列,高级别证据缺乏。Bowen病、AK的激光预治疗联合PDT证据相对充分。毛发领域点阵激光+米诺地尔、+PRP、激光输送曲安奈德/比马前列素均见增密,2026年meta分析显示点阵激光单用密度+102.23根/cm²;儿童斑秃综述仅见308nm准分子激光。压力-真空灌注与声波装置属LADD技术探索;SUI、外阴LS、黄瘤、慢性湿疹、毛发角化病等有小型RCT/病例报告,角化棘皮瘤、淋巴管瘤、Dowling-Degos仅个例。整体局限:样本小、参数与方案不统一、随访短,鼻赘与化脓性汗腺炎尚无标准化治疗共识。
[175], 39864346: 鼻赘观察性研究中,剥脱性点阵CO2激光美容优良率71%,冷刀手术75%,仅1例中度满意,作者推荐两种方法均可作为治疗选项。
[176]: n=20左右互照RCT,点阵CO2+长脉冲Nd:YAG 1064nm联合侧较Nd:YAG单用改善和患者满意度显著更高,治疗化脓性汗腺炎。
[177]: 4例化脓性汗腺炎病例系列,CO2-AFL辅助曲安奈龙给药(±IPL),POSAS降低9~30、DLQI降低6.6~9,满意度高且无不良反应。
[178]: 病例报告显示腋部化脓性汗腺炎CO2切除后应用点阵CO2激光,慢性溃疡快速愈合并改善肩部活动范围,可作为微创手术愈合辅助。
[179]: 10例志愿者随机对照先导研究,四区设计评估消融点阵CO2激光预处理能否增强含肾上腺素的阿替卡因及EMLA膏的局部麻醉效果(用于皮肤操作)。
[180], 26741378: LADD技术探索:压力-真空-压力(PVP)循环主动填充点阵CO2激光微通道(深通道达1200µm)以增强药物沉积;5患者4部位体内荧光显微证实声波装置增强点阵激光后ALA透皮渗透。
[181], 39388586: 掌部多汗症:点阵CO2激光透皮输送75单位A型肉毒毒素与50单位注射临床等效且注射侧疼痛显著更高;激光输送肉毒毒素与氯化铝疗效相当,肉毒毒素组无病期更长。
[182], 34664357: 甲银屑病:点阵CO2激光辅助外用甲氨蝶呤与病灶内注射疗效相当(总NAPSI组间无显著差异p=.18);点阵CO2+他扎罗汀较他扎罗汀单用mNAPSI下降更显著(p=0.001)。
[183], 38858829: 系统性综述:7项RCT均显示点阵CO2激光联合外用治疗甲银屑病有不同程度改善,中度疼痛可经表麻控制,常见红斑、肿胀、结痂;综述纳入PDL、Nd:YAG、FCL共19项研究,认为激光可增强外用药递送。
[184], 31025207: 甲真菌病120例三臂RCT显示激光+特比萘芬类外用( tioconazole)完全改善率55%,高于激光单用30%和外用药单用25%;30例研究中激光组与联合组均显著改善(P=0.036/0.02)。
[185], 40887881: 激光联合PDT:2次10600nm点阵CO2+PDT临床与真菌学治愈p=0.00005,72%完全满意;45例三臂研究中PDT+点阵CO2联合组最佳,86.7%检测转阴、26.7%完全清甲。
[186], 39528688: 真实世界96例点阵CO2+外用抗真菌平均7.7次治疗,仅15.6%完全应答、25%部分应答、59.4%无应答;RCT中点阵CO2+硫康唑OSI从16.17降至10.92(p=0.026),Q开关Nd:YAG组无显著改善(p=0.92)。
[187], 30886476: 斑秃20例自体对照:末次治疗3个月点阵CO2激光较病灶内曲安奈德注射改善更显著;10例难治性斑秃病例系列激光+曲安奈德喷雾8例完成者中7例完全恢复。
[188], 36209381: 60例四臂研究比较点阵CO2与微针(Dermapen)输送曲安奈德或PRP,各组再生评分均显著改善且组间差异显著(P=0.001、P=0.008);激光+曲安奈德与微针+曲安奈德总体无显著差异,黑点微针组多于激光组(46.7% vs 13.3%),首次随访应答差异显著。
[189], 25260052: 20例自体对照RCT中点阵CO2联合比马前列素组SALT平均改善46.43%(两组均显著下降);5例斑秃用消融点阵RF/CO2+曲安奈德+声波压力波透皮递送,5例全部完全恢复。
[190], 34981272: 雄激素性脱发:45例男性MAGA设激光+米诺地尔、激光单用、米诺地尔单用三组评估激光改善米诺地尔递送;半头对比点阵激光+PRP,10次治疗,22mJ/400点cm²高能量每周总密度增幅1.42根/cm²显著高于12mJ/800点低能量(p=0.023)。
[191], 33630354: AGA系统综述与meta分析(37项、3298例):LLLT密度+18.56根/cm²、毛干+10.62µm,LLLT+米诺地尔优于米诺地尔单用(+11.75),点阵激光单用密度+102.23根/cm²;儿童斑秃系统综述89篇中仅列308nm准分子激光(应答77%),未涉及CO2激光。
[192], 33711530: Bowen病17例中点阵CO2预处理+依匹格伦凝胶组完全缓解88.9%(8/9,整体52.9%);头面部AK的AFXL预处理+协同PDT,96.4%患者AKASI显著降低,中位降幅75.5%(基线5.3→1.6)。
4.8 安全性、肤色与并发症
本文件共16篇题录,安全性证据高度集中于剥脱性点阵CO2激光的妇科应用(绝经泌尿生殖综合征GSM、外阴阴道萎缩、性功能障碍、压力性尿失禁),皮肤美容类仅5篇。主流结论:阴道应用中系统综述、对照aware-meta分析(comparator-aware meta-analysis,即比较组敏感的meta分析)及多项RCT均报道”有效且安全”,不良事件以轻中度为主;乳腺癌幸存者可行性研究(64例)与低剂量18W激光研究(50例)明确记录无严重或显著不良事件。疼痛证据集中于III期双盲RCT:纳米胶囊利多卡因-普鲁卡因表麻(120例,皮肤类型I–III,VAS于0/30/60/90分钟评估,含系统性与皮肤迟发反应及药代动力学);图像引导自动触发技术通过保证100%重复性避免脉冲重叠及由此产生的副作用,属于恢复期/剂量安全的技术手段。主要局限为结局主观、对照异质(sham vs非sham)及程序与期望效应,需Cochrane RoB2与GRADE评估。文件中无Fitzpatrick IV–VI深色皮肤、炎症后色素沉着(PIH)专项研究,皮肤分型仅出现I–III,长期致癌/恶性结局亦缺失,相关主题证据在本文件中为空白,不宜据此推断深色皮肤安全性结论。
[193]: 本主题安全证据主要围绕GSM;既往针对CO2点阵激光妇科应用证据有限,无法得出疗效与安全性结论,目前已有随机对照试验数据可评估。
[194]: 系统综述纳入9项研究,妇科癌症幸存者的VVA接受点阵CO2激光可改善症状与性功能,仅发生非重度不良事件,结论为有效且安全的治疗选择。
[195]: 64例乳腺癌幸存者单臂可行性研究,以80%患者完成治疗且无严重不良事件(SAE)为可行性标准,88%受试者完成,安全性可接受。
[196]: 25例绝经与25例非绝经症状患者使用18W低剂量微fractionated激光2次,研究期间未记录到重要不良事件,显示低能量设备安全性良好。
[197]: 47例43–80岁女性阴道点阵CO2激光,每次随访评估疼痛与瘙痒,阴道干燥、性交痛、排尿急迫等VAS显著改善(p<0.001),结论为有效且安全。
[198]: 首个多中心、随机、双盲、sham对照试验评估前庭痛妇女接受前庭CO2激光的安全性与疗效,70例按2:1分配,每4周3次,用FSFI、McGill疼痛量表等评估。
[199]: 84例女性随机RCT,12个月随访全程记录不良事件,激光组润滑、疼痛、满意度自对比显著改善,润滑评分高于Kegel组(P<0.05)。
[200]: 62例绝经后女性三臂RCT,每次能量治疗后评估不良效应,比较CO2激光、微消融射频与局部雌激素对性功能与GSM症状的影响。
[201]: 限定CO2-only RCT的comparator-aware meta分析,按sham与非sham对照做亚组,指出结局主观易受程序与期望效应影响,用Cochrane RoB2和GRADE评估安全性与短期疗效证据确定性。
[202]: 皮肤光型I–III患者(n=120)接受额部ablative fractional CO2激光的双盲III期试验,评估2.5%利多卡因+2.5%普鲁卡因纳米乳膏(nanorap)在0/30/60/90分钟VAS镇痛效果、系统性不良事件、即刻与迟发皮肤反应及药代动力学,为恢复期疼痛管理提供高级别证据。
[202]: 本文件中唯一明确按皮肤光型(Fitzpatrick I–III)限定人群的研究;文件内无Fitzpatrick IV–VI深色皮肤激光研究,即深色皮肤安全性与PIH证据在本文件中缺失。
[203]: 指出激光操作需手动触发易致脉冲重叠与副作用,基于图像分析的自动触发实现100%重复性、精确匹配相邻剂量,从剂量控制层面减少副作用。
[204]: 眼周暗圈分侧自身对照RCT,30例每侧4次、间隔2周,点阵CO2激光与carboxytherapy的评估以患者与医生满意度及标准化照片为主,安全性终点未详细分级。
[205]: 22例轻中度斑块型银屑病随机对照,fractional CO2激光后即刻连续5天涂环孢素霜对比氯倍他索,以临床评分与组织病理评估,旨在补足常规治疗在有效性与安全性上的不足。
[206]: 文献综述称fractional CO2在内的多种激光治疗皮肤利什曼病疗效高、副作用谱低,可作标准治疗的替代,但仍需更多研究评估安全性。
[207]: 综述报道microablative fractional CO2激光治疗压力性尿失禁,6个月ICIQ-UI-SF显著改善、治愈率21%–38%,1小时尿垫试验2–6个月客观改善,6至24–36个月效应下降,安全性为新微创方案提供依据。
[208]: 42例尿失禁女性每月1次共4次CO2激光、随访12个月VAS,报告0–10分主观结局,<55岁组阴道萎缩比例13%(3/23),对照分析用于评估疗效与可行性。
[209]: 复发性阴道念珠菌病1:1匹配先导研究(15激光vs15抗真菌),比较症状改善、满意度与1年内复发,评价激光作为妇科新选项的安全性证据仍不足。
[201], 38385733: 文件中无PIH、Fitzpatrick IV–VI、深色皮肤激光剥脱、长期肿瘤结局等专项研究;GSM证据受对照异质与主观结局限制,深色皮肤安全性结论无法从本文件得出。
5. 小结与展望
5. 小结与展望
综观全部证据,点阵CO2激光的机制认识已从可控热损伤深化到细胞与分子层面:MTZ几何参数可量化,早期炎症细胞(尤其中性粒细胞)是疗效调控靶点,巨噬细胞表型转换、TGF-β/MMP/热休克轴与胶原-弹性纤维重塑构成组织学结局的主线;色素机制上黑素细胞数量与酪氨酸酶通路被下调。临床层面,痤疮瘢痕、烧伤与增生性瘢痕、手术瘢痕的疗效获得系统评价与meta分析支持,联合治疗(PRP、皮下剥离、PDL、激素/肉毒毒素递药、生长因子)呈增强趋势,而参数与介入时机仍无共识。深肤色人群的PIH风险、超参数治疗导致的严重瘢痕与睑外翻是明确的安全边界。未来方向包括:标准化VSS/POSAS联合3D影像与超声的客观终点、单细胞与空间转录组解析修复级联、激光辅助递药时机的临床转化,以及儿童与深色皮肤的队列证据积累。
参考文献
- Geronemus RG. Fractional photothermolysis: current and future applications. Lasers Surg Med.. PMID:16532440.
- Omi T. The Role of the CO2 Laser and Fractional CO2 Laser in Dermatology. Laser Ther.. PMID:24771971.
- Hantash BM. Fractional photothermolysis: a novel aesthetic laser surgery modality. Dermatol Surg.. PMID:17451574.
- Hantash BM. Laser-induced transepidermal elimination of dermal content by fractional photothermolysis. J Biomed Opt.. PMID:16965143.
- Laubach H. Effects of skin temperature on lesion size in fractional photothermolysis. Lasers Surg Med.. PMID:17252573.
- Alster TS. The use of fractional laser photothermolysis for the treatment of atrophic scars. Dermatol Surg.. PMID:17338686.
- Behroozan DS. Fractional photothermolysis for the treatment of surgical scars: a case report. J Cosmet Laser Ther.. PMID:16581684.
- Glaich AS. Fractional photothermolysis for the treatment of postinflammatory erythema resulting from acne vulgaris. Dermatol Surg.. PMID:17598852.
- Naito SK. Fractional photothermolysis treatment for resistant melasma in Chinese females. J Cosmet Laser Ther.. PMID:17763024.
- Jih MH. Fractional photothermolysis for photoaging of hands. Dermatol Surg. 2007. PMID:18053047.
- Zhang L. An Overview of the Mechanisms of Fractional CO2 Laser in Scar Treatment. Lasers Med Sci. 2026. PMID:41766024.
- Mu YZ. The efficacy of fractional ablative carbon dioxide laser combined with other therapies in acne scars. Dermatol Ther. 2019. PMID:31496020.
- Fredman G. Visualization of energy-based device-induced thermal tissue alterations using bimodal ex-vivo confocal microscopy with digital staining. A proof-of-concept study. Skin Res Technol. 2022. PMID:35411961.
- Motta MM. Lower energy and pulse stacking. A safer alternative for skin tightening using fractional CO2 laser. Acta Cir Bras.. PMID:26840353.
- de Filippi Sartori J. “Split-Face” Evaluation of Collagen Changes Induced by Periorbital Fractional CO2 Laser Resurfacing. Aesthet Surg J.. PMID:34618888.
- Jordão JM. Low-fluence and low-density CO2 laser: histological analysis of collagen fiber changes in skin and its clinical repercussions in photorejuvenation. Lasers Med Sci. 2021. PMID:34009520.
- Lee SJ. Dermal Remodeling of Burn Scar by Fractional CO2 Laser. Aesthetic Plast Surg. 2016. PMID:27519176.
- Keshk ZS. Fractional carbon dioxide laser treatment of hypertrophic scar clinical and histopathological evaluation. Lasers Med Sci. 2025. PMID:40069407.
- Wiinberg M. Ablative fractional CO2 laser treatment promotes wound healing phenotype in skin macrophages. Lasers Surg Med. 2024. PMID:38409449.
- Zheng W. Neutrophils and their extracellular traps impair ablative fractional carbon dioxide laser-induced dermal remolding in mice. Lasers Surg Med. 2022. PMID:35181891.
- Tawfic SO. Fractional microneedle radiofrequency versus fractional carbon dioxide laser in the treatment of postburn hypertrophic scars. Lasers Surg Med. 2022. PMID:35900305.
- Ross SW. Fractional ablative laser therapy for the treatment of severe burn scars: A pilot study of the underlying mechanisms. Burns. 2023. PMID:36642662.
- Zhang J. Effectiveness of artesunate combined with fractional CO2 laser in a hypertrophic scar model with underlying mechanism. Burns. 2021. PMID:34103199.
- Rodriguez-Menocal L. Assessment of Ablative Fractional CO2 Laser and Er:YAG Laser to Treat Hypertrophic Scars in a Red Duroc Pig Model. J Burn Care Res.. PMID:29718376.
- Hasegawa K. Single-cell transcriptome analysis of fractional CO2 laser efficiency in treating a mouse model of alopecia. Lasers Surg Med. 2022. PMID:35916125.
- Bueno RSC. Photobiomodulation as a modulator of collagen remodeling following fractional CO₂ laser therapy. Lasers Med Sci. 2025. PMID:40789786.
- Gong C. Low-level green laser promotes wound healing after carbon dioxide fractional laser therapy. J Cosmet Dermatol. 2022. PMID:35947511.
- Kim MS. Tranexamic Acid Diminishes Laser-Induced Melanogenesis. Ann Dermatol. 2015. PMID:26082580.
- El-Sinbawy ZG. Clinical & ultrastructural evaluation of the effect of fractional CO2 laser on facial melasma. Ultrastruct Pathol. 2019. PMID:31575311.
- Kositratna G. Rapid fibrin plug formation within cutaneous ablative fractional CO2 laser lesions. Lasers Surg Med. 2015. PMID:26388136.
- Nguyen L. In vivo characterization of laser-assisted delivery of hyaluronic acid using multiphoton fluorescence lifetime imaging. Exp Dermatol. 2023. PMID:37846872.
- Na JI. Rapid healing and reduced erythema after ablative fractional carbon dioxide laser resurfacing combined with the application of autologous platelet-rich plasma. Dermatol Surg.. PMID:21481064.
- Abdel-Maguid EM. Efficacy of stem cell-conditioned medium vs. platelet-rich plasma as an adjuvant to ablative fractional CO2 laser resurfacing for atrophic post-acne scars: a split-face clinical trial. J Dermatolog Treat. 2019. PMID:31180258.
- Yang Q. Effect of fractional carbon dioxide laser combined with recombinant bovine basic fibroblast growth factor gel in the treatment of mature scar after facial scald burns: a retrospective cohort study. Lasers Med Sci. 2025. PMID:40789953.
- Wu HH. Combination of fractional carbon dioxide laser with recombinant human collagen in periocular skin rejuvenation. J Cosmet Dermatol. 2023. PMID:37526257.
- Zerbinati N. Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment. Lasers Med Sci. 2014. PMID:25410301.
- Salvatore S. Early Regenerative Modifications of Human Postmenopausal Atrophic Vaginal Mucosa Following Fractional CO2 Laser Treatment. Open Access Maced J Med Sci. 2018. PMID:29483970.
- Li B. Efficacy and adverse reactions of fractional CO2 laser for atrophic acne scars and related clinical factors: A retrospective study on 121 patients. J Cosmet Dermatol. 2022. PMID:35181995.
- Helou J. Searching predictive factors of efficacy and safety in a fractional CO2 laser. Dermatol Ther. 2020. PMID:32639071.
- Wu N. A meta-analysis of fractional CO2 laser combined with PRP in the treatment of acne scar. Lasers Med Sci. 2020. PMID:32827074.
- Chen J. Fractional Carbon Dioxide Laser or Erbium:Yttrium-Aluminum-Garnet Laser Assisted by Topical Application/Intradermal Injection of Platelet-Rich Plasma for Postacne Scars. Plast Reconstr Surg.. PMID:34847111.
- El-Hawary EE. Ablative Fractional Carbon Dioxide Laser and Autologous Platelet-Rich Plasma in the Treatment of Atrophic Acne Scars: A Comparative Clinico-Immuno-Histopathological Study. Lasers Surg Med. 2020. PMID:32770685.
- Priya D. A Split Face Comparative Interventional Study to Evaluate the Efficacy of Fractional Carbon Dioxide Laser against Combined use of Fractional Carbon Dioxide Laser and Platelet-Rich Plasma in the Treatment of Acne Scars. Indian Dermatol Online J. 2023. PMID:37266087.
- Zhou S. Efficacy and safety of recombinant human epidermal growth factor combined with fractional carbon dioxide laser for facial atrophic acne scars: a systematic review and meta-analysis of randomized trials. Lasers Med Sci. 2026. PMID:42168448.
- Neinaa YME. Fractional carbon dioxide laser-assisted delivery of lyophilized-growth factors is a promising treatment modality of post-acne scars. Dermatol Ther. 2020. PMID:33131170.
- Zhang J. Efficacy of fractional CO2 laser therapy combined with hyaluronic acid dressing for treating facial atrophic acne scars: a systematic review and meta-analysis of randomized controlled trials. Lasers Med Sci. 2023. PMID:37723352.
- Li X. Fractional carbon dioxide laser combined with subcision for the treatment of three subtypes of atrophic acne scars: a retrospective analysis. Lasers Med Sci. 2023. PMID:37639055.
- Alegre-Sánchez A. Subdermal Laser-Assisted Scar Subcision (SLASS) Combined With Fractional CO2 Laser for Acne Scars: Efficacy Evaluation. J Cosmet Dermatol.. PMID:40296542.
- Tran BQ. Simultaneous versus sequential fractional CO2 laser and subcision combination for management of post-acne atrophic scars: A split-face comparative study. J Cosmet Dermatol. 2024. PMID:38770894.
- Sabry HH. Q-Switched 1064-nm Nd: YAG laser versus fractional carbon dioxide laser for post acne scarring: A split-face comparative study. Photodermatol Photoimmunol Photomed. 2022. PMID:35020221.
- Qu L. Comparison of Non-insulated Microneedle Fractional Radiofrequency and Ablative Fractional Carbon Dioxide Laser for the Treatment of Facial Atrophic Acne Scarring: A Pilot Randomized Split-face Clinical Study. Acta Derm Venereol. 2025. PMID:40568948.
- Kimwattananukul K. Topical 0.5% Timolol Maleate Significantly Enhances Skin-Barrier Restoration After Fractional Carbon Dioxide Laser Treatment for Acne Scars. Lasers Surg Med. 2020. PMID:33211352.
- Tawfic SO. Tranexamic acid versus fractional carbon dioxide laser in post-acne hyperpigmentation. Dermatol Ther. 2021. PMID:34414642.
- Mahar PD. Improvement of Burn Scars Treated With Fractional Ablative CO2 Lasers-A Systematic Review and Meta-analysis Using the Vancouver Scar Scale. J Burn Care Res.. PMID:32805053.
- Abi Zeid Daou C. The use of laser monotherapy in the treatment of keloids and hypertrophic scars: A look at the carbon dioxide laser. A systematic review and meta-analysis. Lasers Med Sci. 2025. PMID:40962972.
- Issler-Fisher AC. Ablative fractional CO2 laser for burn scar reconstruction: An extensive subjective and objective short-term outcome analysis of a prospective treatment cohort. Burns. 2016. PMID:27707636.
- Issler-Fisher AC. Effectiveness and safety of ablative fractional CO2 laser for the treatment of burn scars: A case-control study. Burns. 2020. PMID:33121852.
- Patel SP. Fractional CO2 Laser Treatment Outcomes for Pediatric Hypertrophic Burn Scars. J Burn Care Res.. PMID:31225898.
- Bergus KC. Impact of laser treatment on hypertrophic burn scars in pediatric burn patients. Burns. 2024. PMID:38719695.
- Tan J. Hypertrophic Scar Improvement by Early Intervention With Ablative Fractional Carbon Dioxide Laser Treatment. Lasers Surg Med. 2020. PMID:32677058.
- Clayton NA. Ablative Fractional Resurfacing in Acute Care Management of Facial Burns: A New Approach to Minimize the Need for Acute Surgical Reconstruction. J Burn Care Res.. PMID:30847482.
- Radmanesh M. Fractional CO2 laser is as effective as pulsed dye laser for the treatment of hypertrophic scars. J Dermatolog Treat. 2019. PMID:31697183.
- Ghassemi M. Evaluating the combination and comparison of ablative fractional lasers (CO2, Erbium-YAG) with pulsed dye laser (PDL) for treating hypertrophic scars: a systematic review. Lasers Med Sci. 2025. PMID:40055224.
- Issler-Fisher AC. Ablative fractional resurfacing with laser-facilitated steroid delivery for burn scar management: Does the depth of laser penetration matter? Lasers Surg Med. 2019. PMID:31571242.
- Kivi MK. The efficacy, satisfaction, and safety of carbon dioxide (CO2) fractional laser in combination with pulsed dye laser (PDL) versus each one alone in the treatment of hypertrophic burn scars: a single-blinded randomized controlled trial. Lasers Med Sci. 2024. PMID:38376542.
- Yin Z. Combination therapy of pulsed dye laser and ablative fractional carbon dioxide laser for the treatment of pediatric postburn scar: a systematic review. Lasers Med Sci. 2025. PMID:39918788.
- Li P. Pulsed dye laser, fractional CO2 laser, or combination for burn scar treatment: a systematic review. Lasers Med Sci. 2025. PMID:41003790.
- Neema S. Efficacy of fractional carbon dioxide laser-assisted drug delivery in the management of post-burn scars – A prospective study. J Cutan Aesthet Surg. 2024. PMID:39483650.
- Zhao Y. Energy-based devices for enhanced transdermal drug delivery in pathological scars: A review. Lasers Med Sci. 2026. PMID:42684515.
- Tawaranurak N. Combination of fractional carbon dioxide laser and topical triamcinolone vs intralesional triamcinolone for keloid treatment: A randomised clinical trial. Int Wound J. 2022. PMID:35166029.
- Zhou J. Treatment of hypertrophic scars with ablative fractional carbon dioxide laser assisted with different topical triamcinolone delivery ways. Heliyon. 2023. PMID:38125450.
- Wang J. Combination therapy of refractory keloid with ultrapulse fractional carbon dioxide (CO2 ) laser and topical triamcinolone in Asians-long-term prevention of keloid recurrence. Dermatol Ther. 2020. PMID:33002270.
- Alexander S. Efficacy of fractional CO2 laser with intralesional steroid compared with intralesional steroid alone in the treatment of keloids and hypertrophic scars. J Cosmet Dermatol. 2019. PMID:30770627.
- Fahim A. Treatment of hypertrophic scars using fractional CO2 laser alone in comparison with adding botulinium toxin either intalesional injection or assisted drug delivery. Lasers Med Sci. 2026. PMID:42825928.
- Jiang B. Comparison of dual-plane micro-drop injection of botulinum toxin type A with two traditional methods for treating hypertrophic scars in the tension zone: A long-term clinical application study. J Cosmet Dermatol. 2024. PMID:38803042.
- Jiang H. Efficacy and safety of fractional carbon dioxide laser followed by 5-aminolevulinic acid photodynamic therapy for keloids. Photodiagnosis Photodyn Ther. 2024. PMID:38242189.
- Godara S. A Comparative Study on the Efficacy of Fractional CO2 Laser and Fractional CO2 Laser with Autologous Platelet-Rich Plasma in Scars. Indian Dermatol Online J. 2020. PMID:33344342.
- Dilmaghani S. Impact of pentoxifylline on efficacy, safety, tolerability, and treatment satisfaction of fractional carbon dioxide laser in patients with burn scars: a pilot blinded randomized controlled trial. Lasers Med Sci. 2025. PMID:40178694.
- Atefi N. Evaluation of the efficacy, safety, and satisfaction rate of topical latanoprost in patients with hypopigmented burn scars treated with fractional CO2 laser: a double-blind randomized controlled clinical trial. Lasers Med Sci. 2025. PMID:39779541.
- Lee YI. Combined Therapeutic Strategies for Keloid Treatment. Dermatol Surg.. PMID:30640767.
- Nishi N. A Comparative Study of Effectiveness of Cryotherapy with Intralesional Triamcinolone Vs Fractional CO2 Laser with Topical Betamethasone for the Treatment of Keloids. J Cutan Aesthet Surg.. PMID:36561405.
- Choi JE. Ablative fractional laser treatment for hypertrophic scars: comparison between Er:YAG and CO2 fractional lasers. J Dermatolog Treat. 2013. PMID:23621348.
- Nobari NN. A systematic review of the comparison between needling (RF-needling, meso-needling, and micro-needling) and ablative fractional lasers (CO2, erbium YAG) in the treatment of atrophic and hypertrophic scars. Lasers Med Sci. 2023. PMID:36749436.
- Liu H. Ablative fractional carbon dioxide laser improves quality of life in patients with extensive burn scars: A nested case-control study. Lasers Surg Med. 2022. PMID:36116066.
- Lv K. Ablative fractional CO2 laser surgery improving sleep quality, pain and pruritus in adult hypertrophic scar patients: a prospective cohort study. Burns Trauma. 2021. PMID:34322556.
- Liu H. Ablative Fractional Carbon Dioxide Laser Surgery Improves Sleep Disorder in Pediatric Patients With Hypertrophic Scars. J Burn Care Res.. PMID:41482863.
- Issler-Fisher AC. Ablative fractional resurfacing for burn scar management affects the number and type of elective surgical reconstructive procedures, hospital admission patterns as well as length of stay. Burns. 2019. PMID:31848087.
- Ji Q. Fractional CO2 Laser to Treat Surgical Scars: A System Review and Meta-Analysis on Optimal Timing. J Cosmet Dermatol.. PMID:39780524.
- Shen S. The Efficacy of Fractional Carbon Dioxide Laser in Surgical Scars Treatment: A system Review and Meta-analysis. Aesthetic Plast Surg. 2022. PMID:35666282.
- Chen L. Treatment of Surgical Scars with Fractional Carbon Dioxide (CO2) Laser: A Randomized Controlled Trial. Adv Wound Care (New Rochelle). 2026. PMID:39869009.
- Corbella-Bagot L. The role of fractional CO2 laser therapy in post-surgical skin cancer scarring. J Cosmet Laser Ther. 2026. PMID:41702607.
- Wyss N. Fractional CO2 laser to improve noticeable scars after skin cancer surgery: An appraisal by the patients, laypersons, and experts. Dermatol Ther. 2021. PMID:34022110.
- You HJ. The Outcome of Early Ablative Fractional Laser Treatment for Thyroidectomy Scars. Lasers Surg Med. 2020. PMID:31950524.
- Huang CY. Comparative Efficacy of Fractional CO2 Laser Combined with Topical Steroid Cream versus Solution for Post-Thyroidectomy Scar Treatment: A Prospective Study. Healthcare (Basel). 2024. PMID:39201163.
- Shadad M. Use of Fractional CO2 Laser in Cleft Lip Scars: Does It Make a Difference? Ann Plast Surg.. PMID:32826442.
- Jahanbin A. Fractional CO2 laser treatment for post-surgical lip scars in cleft lip and palate patients. Lasers Med Sci. 2019. PMID:31187297.
- Zhang N. Fractional CO2 laser therapy for cesarean scar under the guidance of multiple evaluation methods: A retrospective study. J Cosmet Dermatol. 2020. PMID:33185305.
- Ibrahim SM. Early fractional carbon dioxide laser intervention for postsurgical scars in skin of color. Clin Cosmet Investig Dermatol. 2019. PMID:30655685.
- Qiang S. Timing of Laser Intervention on Facial Scars: A 3D Imaging and Scar Scale Analysis in a Retrospective Study. Lasers Surg Med. 2024. PMID:39308039.
- Makki M. Efficacy of platelet-rich plasma plus fractional carbon dioxide laser in treating posttraumatic scars. Dermatol Ther. 2019. PMID:31344305.
- Guo L. Efficiency of Early Sequential Laser Treatment for Facial Linear Scars in Cross-Sectional Regions. J Cosmet Dermatol.. PMID:39943911.
- Cervelli V. Ultrapulsed fractional CO2 laser for the treatment of post-traumatic and pathological scars. J Drugs Dermatol.. PMID:21061753.
- Pai AH. Fractional carbon dioxide laser for facial scarring due to windscreen glass shatter injury. J Cosmet Dermatol. 2020. PMID:32500543.
- Weiss ET. Successful treatment of atrophic postoperative and traumatic scarring with carbon dioxide ablative fractional resurfacing: quantitative volumetric scar improvement. Arch Dermatol.. PMID:20157023.
- Zhang MX. Evaluation of combining ultrapulse CO2 with fractional CO2 laser for the treatment of atrophic scars in Asians. Lasers Med Sci. 2024. PMID:38453744.
- Chen R. Efficacy of combining erbium:YAG and fractional CO2 laser for the treatment of facial scarring. Eur J Dermatol.. PMID:36856396.
- Osman MA. Fractional Er:YAG laser versus fractional CO2 laser in the treatment of immature and mature scars: a comparative randomized study. Arch Dermatol Res. 2024. PMID:38236287.
- Tierney EP. Ablative fractionated CO2, laser resurfacing for the neck: prospective study and review of the literature. J Drugs Dermatol.. PMID:19663109.
- Stebbins WG. Ablative fractional CO2 resurfacing for photoaging of the hands: pilot study of 10 patients. Dermatol Ther.. PMID:21276159.
- Kotlus BS. Upper Eyelid Fractional CO2 Laser Resurfacing With Incisional Blepharoplasty. Ophthalmic Plast Reconstr Surg.. PMID:26505229.
- Ellis MM. Unconventional use of ablative fractional photothermolysis in arm contouring. J Cosmet Laser Ther. 2020. PMID:32496930.
- Fife DJ. Complications of fractional CO2 laser resurfacing: four cases. Lasers Surg Med.. PMID:19291745.
- Duplechain JK. Severe neck scarring: A consequence of fractional CO2 laser resurfacing. J Cosmet Laser Ther. 2016. PMID:27115980.
- Artzi O. Fractional Ablative CO2 Laser Followed by Topical Application of Sodium Stibogluconate for Treatment of Active Cutaneous Leishmaniasis: A Randomized Controlled Trial. Acta Derm Venereol.. PMID:30281141.
- Nilforoushzadeh MA. Comparison the efficacy of ablative CO2 laser and fractional CO2 laser on the healing of cutaneous leishmaniasis scars. Adv Biomed Res. 2014. PMID:25625098.
- Alegre-Sánchez A. Laser-Assisted Drug Delivery. Actas Dermosifiliogr (Engl Ed). 2018. PMID:30266385.
- Madegowda SB. Efficacy of Fractional Carbon Dioxide Laser versus Fractional Carbon Dioxide Laser with Platelet-Rich Plasma in Treatment of Striae Distensae in a Tertiary Care Center: A Comparative Study. J Cutan Aesthet Surg.. PMID:38189063.
- El Taieb MA. Fractional CO2 Laser Versus Intense Pulsed Light in Treating Striae Distensae. Indian J Dermatol.. PMID:27057017.
- Zhang N. Antera 3D camera: A novel method for evaluating the therapeutic efficacy of fractional CO2 laser for surgical incision scars. J Cosmet Dermatol. 2018. PMID:30084229.
- Xu H. Skin Wound Tension Reduction Device Combined with Ablative Fractional Carbon Dioxide Laser to Reduce Scar Formation After Excision of Pediatric Facial Skin Lesions: A Prospective Cohort Study. Clin Cosmet Investig Dermatol. 2022. PMID:35228810.
- Tierney EP. Clinical and echographic analysis of ablative fractionated carbon dioxide laser in the treatment of photodamaged facial skin. Dermatol Surg. 2010. PMID:21040129.
- Clementoni MT. Non-sequential fractional ultrapulsed CO2 resurfacing of photoaged facial skin: preliminary clinical report. J Cosmet Laser Ther.. PMID:17963138.
- Ciocon DH. A split-face comparison of two ablative fractional carbon dioxide lasers for the treatment of photodamaged facial skin. Dermatol Surg.. PMID:21605239.
- Ancona D. A prospective study of the improvement in periorbital wrinkles and eyebrow elevation with a novel fractional CO2 laser–the fractional eyelift. J Drugs Dermatol.. PMID:20120420.
- Mezzana P. Lower eyelid ablative fractional resurfacing: a new technique to treat skin laxity and photoaging. Acta Chir Plast.. PMID:21749008.
- Robati RM. Efficacy and safety of fractional CO2 laser versus fractional Er:YAG laser in the treatment of facial skin wrinkles. Lasers Med Sci. 2016. PMID:27885522.
- Mahmoud BH. Prospective randomized controlled study to determine the effect of topical application of botulinum toxin A for crow’s feet after treatment with ablative fractional CO2 laser. Dermatol Surg.. PMID:25548849.
- Ibrahim O. Safety of Laser-Assisted Delivery of Topical Poly-L-Lactic Acid in the Treatment of Upper Lip Rhytides: A Prospective, Rater-Blinded Study. Dermatol Surg.. PMID:30608292.
- Du YM. Efficacy and safety of Resveratrol combined with Ablative Fractional CO2 laser system in the treatment of skin photoaging. J Cosmet Dermatol. 2021. PMID:34719113.
- Trelles MA. Fractional carbon dioxide laser and acoustic-pressure ultrasound for transepidermal delivery of cosmeceuticals: a novel method of facial rejuvenation. Aesthetic Plast Surg. 2013. PMID:23812612.
- Qu Y. Clinical observation and dermoscopy evaluation of fractional CO2 laser combined with topical tranexamic acid in melasma treatments. J Cosmet Dermatol. 2021. PMID:33565243.
- Campanati A. Efficacy and Safety of Topical Pidobenzone 4% as Adjuvant Treatment for Solar Lentigines: Result of a Randomized, Controlled, Clinical Trial. Dermatology. 2016. PMID:27513344.
- Eldeeb F. Fractional carbon dioxide laser versus carbon-assisted Q-switched Nd: YAG laser in the treatment of dilated facial pores. J Cosmet Dermatol. 2021. PMID:34169628.
- Yalici-Armagan B. Fractional carbon dioxide laser for facial rejuvenation: A prospective study to evaluate the efficacy and the safety. J Cosmet Laser Ther. 2017. PMID:28759274.
- Piccolo D. A faster CO2 fractional scanner system mode for skin rejuvenation. A clinical study. Skin Res Technol.. PMID:39164795.
- Duplechain JK. Fractional CO2 resurfacing: has it replaced ablative resurfacing techniques? Facial Plast Surg Clin North Am.. PMID:23731583.
- Zhang A. Efficacy and Safety of Super-pulsed Fractional Carbon Dioxide Laser in the Treatment of Chinese Facial Aging. Dermatol Surg. 2022. PMID:36342259.
- Kim HJ. Fractional Carbon Dioxide Laser as an “Add-on” Treatment for Vitiligo: A Meta-analysis with Systematic Review. Acta Derm Venereol.. PMID:29110015.
- Chiu YJ. Fractional CO2 laser contributes to the treatment of non-segmental vitiligo as an adjunct therapy: a systemic review and meta-analysis. Lasers Med Sci. 2018. PMID:29696444.
- Zhou L. Efficacy and safety of fractional CO2 laser combined with 308 nm excimer laser in non-segmental vitiligo: a meta-analysis with trial sequential analysis. J Cosmet Laser Ther. 2025. PMID:40169273.
- Rokni GR. Fractional CO2 laser combined with narrow-band ultraviolet B (NB-UVB) phototherapy versus NB-UVB monotherapy in vitiligo patients: prospective, self-controlled, and randomized trial. Lasers Med Sci. 2025. PMID:39809953.
- Kim WI. The efficacy of fractional carbon dioxide laser combined with narrow-band ultraviolet B phototherapy for non-segmental vitiligo: a systematic review and meta-analysis. Lasers Med Sci. 2020. PMID:32572662.
- Eşme P. No Additional Benefit of Combining Fractional Carbon Dioxide Laser With Narrow-Band Ultraviolet B Phototherapy for Vitiligo: A Randomized Prospective Study With Half-Body Side Comparison. Dermatol Surg.. PMID:30829772.
- El-Zawahry MB. Effect of combination of fractional CO2 laser and narrow-band ultraviolet B versus narrow-band ultraviolet B in the treatment of non-segmental vitiligo. Lasers Med Sci. 2017. PMID:28748302.
- Weshahy R. Efficacy and safety of combined fractional ablative CO2 laser and 5 fluorouracil in the treatment of acral vitiligo: An open, uncontrolled study. J Cosmet Dermatol. 2022. PMID:35621236.
- Liu L. Ablative fractional Co2 laser aided delivery of long-acting glucocorticoid in the treatment of acral vitiligo: a multicenter, prospective, self-bilateral controlled study. J Dermatolog Treat. 2018. PMID:30081694.
- Ismail SA. Methotrexate Cutaneous Delivery by Fractional CO2 Laser Against 5-Fluorouracil in Stable, Nonsegmental Vitiligo. Dermatol Surg. 2026. PMID:42319271.
- Elgarhy LH. Treatment of stable nonsegmental vitiligo using transdermal delivery of 5-fluorouracil by fractional CO2 laser versus intralesional injection of 5-fluorouracil, both followed by narrow-band type ultraviolet B (UVB): A comparative study. J Cosmet Dermatol. 2022. PMID:35005831.
- Li L. Triple combination treatment with fractional CO2 laser plus topical betamethasone solution and narrowband ultraviolet B for refractory vitiligo: a prospective, randomized half-body, comparative study. Dermatol Ther. 2015. PMID:25753514.
- Abdelghani R. Combined treatment with fractional carbon dioxide laser, autologous platelet-rich plasma, and narrow band ultraviolet B for vitiligo in different body sites: A prospective, randomized comparative trial. J Cosmet Dermatol. 2017. PMID:28834191.
- Chen J. Current art of combination therapy with autologous platelet-rich plasma for stable vitiligo: A meta-analysis. Int Wound J. 2020. PMID:33245822.
- Kadry M. Platelet-rich plasma versus combined fractional carbon dioxide laser with platelet-rich plasma in the treatment of vitiligo: a comparative study. Clin Cosmet Investig Dermatol. 2018. PMID:30510437.
- Yuan J. Investigation of optimal energy or density of a fractional CO2 laser system in the treatment of stable non-segmental vitiligo. Complement Ther Clin Pract. 2022. PMID:36343424.
- Yang Y. Combination therapy of carbon dioxide laser with topical halometason cream and 308 nm excimer laser for the treatment of vitiligo: an optimized combined treatment protocol. Lasers Med Sci. 2026. PMID:42925430.
- Yuan J. Fractional CO2 lasers contribute to the treatment of stable non-segmental vitiligo. Eur J Dermatol.. PMID:27818365.
- Feily A. Fractional CO2 Laser Pretreatment to Autologous Hair Transplantation and Phototherapy Improves Perifollicular Repigmentation in Refractory Vitiligo: A Randomized, Prospective, Half-Lesion, Comparative Study. Dermatol Surg.. PMID:27560291.
- Kim C. Fractional CO2 laser and adjunctive therapies in skin of color melasma patients. JAAD Int. 2022. PMID:35875396.
- Mekawy KMM. Micro-needling versus fractional carbon dioxide laser for delivery of tranexamic acid in the treatment of melasma: A split-face study. J Cosmet Dermatol. 2020. PMID:32562337.
- Tawfic SO. Tranexamic Acid Microinjection Alone Versus Its Combination With Fractional Carbon Dioxide Laser in Melasma Treatment: A Dermoscopic Evaluation. Dermatol Surg. 2022. PMID:35333207.
- Ma W. Efficacy and safety of laser-related therapy for melasma: A systematic review and network meta-analysis. J Cosmet Dermatol. 2023. PMID:37737021.
- Ren R. Efficacy and Safety of Picosecond Laser in the Treatment of Melasma: A Network Meta-analysis. Dermatol Surg. 2023. PMID:37116000.
- Esmat S. Combining Low Power Fractional CO2 With QS-NdYAG Toning in the Treatment of Melasma Reduces the Incidence of Punctate Leukoderma. Lasers Surg Med. 2021. PMID:34164829.
- Mann KK. Nevus of Ota: Combination Treatment with Q-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser and Fractional CO2 Laser. J Cutan Aesthet Surg.. PMID:38189068.
- Lee HE. Nevus sebaceous treated with fractional carbon dioxide laser followed by pulsed dye laser. Indian J Dermatol Venereol Leprol.. PMID:25201863.
- Fouda I. Fractional Carbon Dioxide Laser versus Trichloroacetic Acid 20% Peel in the Treatment of Acanthosis Nigricans: A Split Neck Comparative Study. J Clin Aesthet Dermatol.. PMID:38076653.
- Ghane Y. Efficacy and safety of lasers versus topical medications for acanthosis nigricans and pseudo-acanthosis nigricans treatment: a systematic review. Lasers Med Sci. 2024. PMID:38253899.
- Ghandehari R. Efficacy and safety of fractional CO2 laser and tranexamic acid versus microneedling and tranexamic acid in the treatment of infraorbital hyperpigmentation. J Dermatolog Treat. 2020. PMID:32893707.
- Vachiramon V. Fractional Carbon Dioxide Laser for Keratosis Pilaris: A Single-Blind, Randomized, Comparative Study. Biomed Res Int. 2016. PMID:27247936.
- Kurniawati Y. Effectiveness of Fractional CO2 Laser and Topical Centella asiatica Combination Therapy in Striae Distensae (Stretch Marks). J Lasers Med Sci. 2024. PMID:39650780.
- Preclaro IAC. Efficacy of ablative fractional carbon dioxide laser combined with autologous platelet-rich plasma versus ablative fractional carbon dioxide laser and placebo in the treatment of striae gravidarum: A randomized clinical trial. J Cosmet Dermatol. 2022. PMID:35075752.
- Abdallah M. Ablative fractional CO2 laser vs lyophilized growth factor intralesional injection vs combination of both modalities for striae distensae treatment. J Cosmet Dermatol. 2020. PMID:32640118.
- Saki N. Comparison of the efficacy of microneedling versus CO2 fractional laser to treat striae alba: A randomized clinical trial. Dermatol Ther. 2021. PMID:34796595.
- Hafez V. Photobiomodulation versus fractional carbon dioxide laser for stria alba in phototype III-IV: a randomized controlled study. Lasers Med Sci. 2024. PMID:38890186.
- Chantes A. Clinical improvement of striae distensae in Korean patients using a combination of fractionated microneedle radiofrequency and fractional carbon dioxide laser. Dermatol Surg.. PMID:24852477.
- Amiri SV. Rhinophyma treatment: An observational study comparing the results of the cold blade technique and ablative fractional CO2-laser. J Plast Reconstr Aesthet Surg. 2024. PMID:39709878.
- Abdel Azim AA. Combined fractional carbon dioxide laser and long-pulsed neodymium : yttrium-aluminium-garnet (1064 nm) laser in treatment of hidradenitis suppurativa; a prospective randomized intra-individual controlled study. Int J Dermatol. 2018. PMID:29907956.
- Malkoff N. Combination Ablative Fractional CO 2 Laser, Intense Pulsed Light, and Triamcinolone for the Management of Hidradenitis Suppurativa: A Case Series. Adv Skin Wound Care. 2025. PMID:41537698.
- Nicholson CL. Rapid healing of chronic ulcerations and improvement in range of motion after fractional carbon dioxide (CO2) treatment after CO2 excision of hidradenitis suppurativa axillary lesions: A case report. JAAD Case Rep. 2016. PMID:27051812.
- Meesters AA. Fractional CO2 laser assisted delivery of topical anesthetics: A randomized controlled pilot study. Lasers Surg Med. 2015. PMID:26032635.
- Erlendsson AM. Fractional laser-assisted drug delivery: Active filling of laser channels with pressure and vacuum alteration. Lasers Surg Med. 2015. PMID:26280816.
- Agamia NF. Fractional CO2 Laser for Transcutaneous Drug Delivery of Onabotulinum Toxin in Palmar Hyperhidrosis. Dermatol Surg.. PMID:33337732.
- Alakad R. Fractional CO2 Laser-Assisted Delivery Versus Intralesional Injection of Methotrexate in Psoriatic Nails. Dermatol Surg. 2022. PMID:35333217.
- Tartaglia J. Ablative CO2-Assisted Laser for Topical Drug Delivery in Nail Psoriasis: A Systematic Review. Skin Appendage Disord. 2023. PMID:38572191.
- Zaki AM. Fractional CO2 laser plus topical antifungal versus fractional CO2 laser versus topical antifungal in the treatment of onychomycosis. Dermatol Ther. 2019. PMID:31697010.
- de Oliveira GB. The association of fractional CO2 laser 10.600nm and photodynamic therapy in the treatment of onychomycosis. An Bras Dermatol.. PMID:26375214.
- Lee SK. Real-world effectiveness of a fractional CO2 laser with topical antifungal agents for the treatment of onychomycosis. Dermatol Ther. 2022. PMID:35388594.
- El-Husseiny R. Comparative study between fractional carbon dioxide laser vs intralesional steroid injection in treatment of alopecia areata. Dermatol Ther. 2020. PMID:32478930.
- El Mulla KF. Transepidermal Delivery of Triamcinolone Acetonide or Platelet Rich Plasma Using Either Fractional Carbon Dioxide Laser or Micro-needling in Treatment of Alopecia Areata. Dermatol Pract Concept. 2022. PMID:36534509.
- Meymandi SS. The role of fractional laser-assisted drug delivery in enhancing the efficacy of topical bimatoprost solution in the treatment of alopecia areata: An intra-patient comparative randomized clinical trial. J Cosmet Dermatol. 2024. PMID:38321929.
- Salah M. The Effect of the Fractional Carbon Dioxide Laser on Improving Minoxidil Delivery for the Treatment of Androgenetic Alopecia. J Lasers Med Sci. 2019. PMID:32099624.
- Alahmadi M. Lasers and Energy-Based Devices in the Treatment of Androgenetic Alopecia: A Systematic Review and Meta-Analysis. Skin Appendage Disord. 2026. PMID:42339398.
- Lee DW. Clinical experience of ingenol mebutate gel for the treatment of Bowen’s disease. J Dermatol. 2018. PMID:29383745.
- Gunter J. Fractional CO2 laser for genitourinary syndrome of menopause: evaluating the evidence. Menopause.. PMID:38385733.
- D’Oria O. Fractional Co2 laser for vulvo-vaginal atrophy in gynecologic cancer patients: A valid therapeutic choice? A systematic review. Eur J Obstet Gynecol Reprod Biol. 2022. PMID:36037664.
- Quick AM. Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors. Support Care Cancer. 2019. PMID:31811486.
- Marin J. The results of new low dose fractional CO2 Laser – A prospective clinical study in France. J Gynecol Obstet Hum Reprod. 2019. PMID:31288088.
- Ghanbari Z. Fractional CO2 Laser for Treatment of Vulvovaginal Atrophy: A Short Time Follow-up. J Family Reprod Health.. PMID:33603796.
- Goldstein SW. Safety and efficacy of fractional CO2 laser treatment to the vestibule: a randomized, double-blind, sham-controlled, prospective 3-site clinical study in women with vestibular pain. J Sex Med.. PMID:36779572.
- Lou W. A randomized controlled study of vaginal fractional CO2 laser therapy for female sexual dysfunction. Lasers Med Sci. 2021. PMID:33723687.
- Seganfredo IB. Comparison of promestriene with vaginal fractional CO2 laser and radiofrequency treatments of genitourinary syndrome of menopause. Maturitas. 2024. PMID:38714422.
- Zulfikaroglu E. Fractional CO2 Laser for Genitourinary Syndrome of Menopause: Comparator-Aware Systematic Review and Meta-Analysis. Int Urogynecol J. 2026. PMID:42593504.
- Gobbato C. Randomized, double-blind, phase III clinical study of a novel nanotechnological topical anesthetic formulation containing lidocaine 25 mg/g and prilocaine 25 mg/g (nanorap) in skin phototypes I-III patients with ablative fractional CO2 laser treatment indication in the forehead. Lasers Surg Med. 2019. PMID:30811630.
- Wilczyński S. Image-guided automatic triggering of a fractional CO2 laser in aesthetic procedures. Comput Biol Med. 2016. PMID:27348182.
- Zaheri H. Comparison of the efficacy of carboxytherapy versus fractional CO2 laser therapy for the treatment of periorbital dark circles: A randomized clinical trial. J Cosmet Dermatol. 2022. PMID:36065678.
- Helmy A Y. Efficacy of the topical cyclosporine cream assisted by fractional carbon dioxide laser vs topical clobetasol cream for the treatment of plaque psoriasis: Randomized comparative study. J Cosmet Dermatol. 2021. PMID:34791789.
- Siadat AH. Application of laser for treatment of cutaneous leishmaniasis: a review of literature. Lasers Med Sci. 2020. PMID:32333334.
- Ruffolo AF. Vaginal Laser Therapy for Female Stress Urinary Incontinence: New Solutions for a Well-Known Issue-A Concise Review. Medicina (Kaunas). 2022. PMID:35454351.
- Luvero D. The efficacy and feasibility of fractional CO2 laser therapy for the treatment of urinary incontinence: a multicentric case-control study. Minerva Obstet Gynecol. 2023. PMID:37140590.
- Plata Puyana JD. Fractional CO₂ Laser Therapy for Recurrent Vulvovaginal Candidiasis: A Matched Observational Pilot Study. J Low Genit Tract Dis. 2026. PMID:42804622.
上传日期:2026 年 11 月 12 日;检索截止日期:2026-11-12
关于本文:本文撰写与审核:吕开阳,执业医师,整形外科(主任医师),上海三甲医院。本站为个人科普站点,内容为医学教育材料,不构成对任何个体的诊疗建议;诊断与治疗方案须由具备资质的医师面诊确定,效果存在个体差异。本站不提供在线诊疗与首诊,就医请通过医院官方渠道挂号。沪ICP备2025119709号-1